While we’ve loved connecting with you on X/Twitter, it's time for a fresh start in a platform that aligns with our values & vision.
Join the conversation & stay updated with all things EFMC-YSN. Let’s build an inclusive and sustainable community together.
Each of the three awards includes:
📄 A diploma
💰 €7,500
🎤 Invitation to deliver a headline presentation at EFMC Medicinal Chemistry 2026
🔗 Apply here: buff.ly/Bcjtt6s
⏱️ Submission deadline: January 31, 2026
Each of the three awards includes:
📄 A diploma
💰 €7,500
🎤 Invitation to deliver a headline presentation at EFMC Medicinal Chemistry 2026
🔗 Apply here: buff.ly/Bcjtt6s
⏱️ Submission deadline: January 31, 2026
Get to know Anne Valade from UCB, Belgium!🧪
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗 Read the full interview here: buff.ly/9PMKV8m
Get to know Anne Valade from UCB, Belgium!🧪
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗 Read the full interview here: buff.ly/9PMKV8m
Join us for the EFMC-YSN Career Webinar. You’ll hear from 5 accomplished young scientists as they share their experiences.
📅 Jan 22, 15:00–17:00 CET
🔗 buff.ly/Ok5ABgI
Join us for the EFMC-YSN Career Webinar. You’ll hear from 5 accomplished young scientists as they share their experiences.
📅 Jan 22, 15:00–17:00 CET
🔗 buff.ly/Ok5ABgI
🎉 Wishing you a joyful festive season and an inspiring New Year ahead!
#YoungScientists #ThankYou #HappyHolidays #NewYear2026
🎉 Wishing you a joyful festive season and an inspiring New Year ahead!
#YoungScientists #ThankYou #HappyHolidays #NewYear2026
Monte Rosa is hiring a Computational Medicinal Chemist to join their innovative team. If you’re passionate about leveraging computational tools to accelerate drug discovery and make a real impact in the biotech space, this is your opportunity!
🔗 Apply now:
Monte Rosa is hiring a Computational Medicinal Chemist to join their innovative team. If you’re passionate about leveraging computational tools to accelerate drug discovery and make a real impact in the biotech space, this is your opportunity!
🔗 Apply now:
This contribution focuses on the article “Toward Anti-Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi’s Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen” by Berwanger et al.
📖 buff.ly/uV9xZ4h
This contribution focuses on the article “Toward Anti-Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi’s Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen” by Berwanger et al.
📖 buff.ly/uV9xZ4h
Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events.
🔗 buff.ly/x5bFcOd
Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events.
🔗 buff.ly/x5bFcOd
Join the EFMC Reviewer Academy, led by editors from Chemistry Europe / Wiley-VCH.
✅ Free online course
✅ Interactive workshop & Q&A (next session: Dec 15)
✅ Hands-on review assignment
👉 Apply now: buff.ly/WHa1PTD
Join the EFMC Reviewer Academy, led by editors from Chemistry Europe / Wiley-VCH.
✅ Free online course
✅ Interactive workshop & Q&A (next session: Dec 15)
✅ Hands-on review assignment
👉 Apply now: buff.ly/WHa1PTD
To celebrate remarkable contributions in Medicinal Chemistry and Chemical Biology, the EFMC will confer three awards in 2026.
⏱️ January 31, 2026
To celebrate remarkable contributions in Medicinal Chemistry and Chemical Biology, the EFMC will confer three awards in 2026.
⏱️ January 31, 2026
Join us to explore Targeting RNA with Small Molecules" with 👨🔬🔬 Federico Riu (Italian Institute of Technology, IT), Elena Mencarelli and Kateryna Demchenko (Université Côte D'Azur, FR).
📅 Dec 9, 13:00 CET/12:00UK.
🔗https://buff.ly/P4eJkNK
Join us to explore Targeting RNA with Small Molecules" with 👨🔬🔬 Federico Riu (Italian Institute of Technology, IT), Elena Mencarelli and Kateryna Demchenko (Université Côte D'Azur, FR).
📅 Dec 9, 13:00 CET/12:00UK.
🔗https://buff.ly/P4eJkNK
📅 December 4
🔗 buff.ly/sacyw1W
📅 December 4
🔗 buff.ly/sacyw1W
We’re looking for motivated early-career researchers to join us as Supporting Members and help shape the future of our community.
📅 Apply by December 16
🔗 buff.ly/Lh0x51d
We’re looking for motivated early-career researchers to join us as Supporting Members and help shape the future of our community.
📅 Apply by December 16
🔗 buff.ly/Lh0x51d
💊 Join us on November 20th for the 2025 MedChemBioPoster Online (#MCBPoster25)!
🧠 From 10 AM to 6 PM, share YOUR research on LinkedIn as a poster and compete to win prizes (up to 150 euros)! 🏆
👉 Register here: buff.ly/vY5o2Fk
💊 Join us on November 20th for the 2025 MedChemBioPoster Online (#MCBPoster25)!
🧠 From 10 AM to 6 PM, share YOUR research on LinkedIn as a poster and compete to win prizes (up to 150 euros)! 🏆
👉 Register here: buff.ly/vY5o2Fk
The EFMC is offering grants to support the participation of young academic scientists in EFMC-organised events.
📅 Deadline: 12 February 2026
🔗 buff.ly/k1bu02U
The EFMC is offering grants to support the participation of young academic scientists in EFMC-organised events.
📅 Deadline: 12 February 2026
🔗 buff.ly/k1bu02U
Discover innovative light-responsive compounds used in modulating biological functions.
📅 Nov. 25
🔗 buff.ly/umzJAAr
Discover innovative light-responsive compounds used in modulating biological functions.
📅 Nov. 25
🔗 buff.ly/umzJAAr
This edition’s contribution will focus on the recently published article “Novel Pyrazolo [1,5-a]−1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models” by D. Carbone et al.
🔗 buff.ly/Glod3p1
This edition’s contribution will focus on the recently published article “Novel Pyrazolo [1,5-a]−1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models” by D. Carbone et al.
🔗 buff.ly/Glod3p1
Get to know Samuele Cazzamalli from Philochem AG, Switzerland!🧪
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗 buff.ly/70Fu4wv
Get to know Samuele Cazzamalli from Philochem AG, Switzerland!🧪
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗 buff.ly/70Fu4wv
Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events.
🔗 buff.ly/xazhYlo
Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events.
🔗 buff.ly/xazhYlo
Join professional editors from Chemistry Europe / Wiley-VCH for a one-day course on writing, publishing, and communication, ideal for early-career researchers.
📅 November 13
⏰ Register by November 10
🔗 buff.ly/Wt7jvqE
Join professional editors from Chemistry Europe / Wiley-VCH for a one-day course on writing, publishing, and communication, ideal for early-career researchers.
📅 November 13
⏰ Register by November 10
🔗 buff.ly/Wt7jvqE
On November 20th, MedChemBioPoster Online (#MCBPoster25) is back!
🏆 Prizes up to 150 euros
⏳ Deadline: November 13th
🔗 www.efmc.info/web/medchemb...
On November 20th, MedChemBioPoster Online (#MCBPoster25) is back!
🏆 Prizes up to 150 euros
⏳ Deadline: November 13th
🔗 www.efmc.info/web/medchemb...
This edition’s provided by Alex Hallatt (University of Dundee, UK) focuses on the article “Inhibition of the Clathrin Terminal Domain—Amphiphysin Protein–Protein Interaction. Probing the Pitstop 2 Aromatic Moiety” by K. Prichard, et al. (ChemMedChem 2025)
This edition’s provided by Alex Hallatt (University of Dundee, UK) focuses on the article “Inhibition of the Clathrin Terminal Domain—Amphiphysin Protein–Protein Interaction. Probing the Pitstop 2 Aromatic Moiety” by K. Prichard, et al. (ChemMedChem 2025)
Join Timo Heinrich, Jakub Gunera and Jesko Fabian Kaiser (Merck, Germany) as they discuss "Investigation of P-site-binding TEAD Inhibitors: Structure-based Optimization and Mode of Action Elucidation".
📅 Dec 4 - 4pm CET
🔗 buff.ly/eQnLJIm
Join Timo Heinrich, Jakub Gunera and Jesko Fabian Kaiser (Merck, Germany) as they discuss "Investigation of P-site-binding TEAD Inhibitors: Structure-based Optimization and Mode of Action Elucidation".
📅 Dec 4 - 4pm CET
🔗 buff.ly/eQnLJIm
Get to know Paria Anastasiou from Max-Planck Institute, DE.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗https://buff.ly/qayWsyu
Get to know Paria Anastasiou from Max-Planck Institute, DE.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗https://buff.ly/qayWsyu
Join us on Oct 10, 1PM for Under Pressure, a free virtual workshop on mental health in academia.
🎙 Lashuel, Cahill & Ho
👉 Register: www.efmc.info/mental-healt...
Join us on Oct 10, 1PM for Under Pressure, a free virtual workshop on mental health in academia.
🎙 Lashuel, Cahill & Ho
👉 Register: www.efmc.info/mental-healt...